Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
93.69B
Market cap93.69B
Price-Earnings ratio
32.40
Price-Earnings ratio32.40
Dividend yield
Dividend yield
Average volume
18.80M
Average volume18.80M
High today
$63.30
High today$63.30
Low today
$62.25
Low today$62.25
Open price
$62.25
Open price$62.25
Volume
1.01M
Volume1.01M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$61.25
52 Week low$61.25

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $63.04. The company's market cap stands at 93.69B, with a P/E ratio of 32.40.

During the trading session on 2026-04-06, Boston Scientific(BSX) shares reached a daily high of $63.30 and a low of $62.25. At a current price of $63.04, the stock is +1.3% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 1.01M, compared to an average daily volume of 18.8M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $61.25.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $61.25.

BSX News

TipRanks 2h
Boston Scientific price target lowered to $80 from $96 at Evercore ISI

Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Boston Scientific (BSX) to $80 from $96 and keeps an Outperform rating on the shares as part...

Simply Wall St 18h
Boston Scientific Valuation After Downgrade Litigation And Concerns Over Slower Growth

Boston Scientific (BSX) is under pressure after a sharp sentiment swing, driven by an analyst downgrade tied to slower expectations in U.S. electrophysiology an...

Boston Scientific Valuation After Downgrade Litigation And Concerns Over Slower Growth
Benzinga 1d
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are the Others in Your Portfolio?

by Nabaparna Bhattacharya Benzinga Editor Follow Nike, Inc. (NYSE:NKE) decreased 14.29% this week after the company reported third-quarter financial results. A...

Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are the Others in Your Portfolio?

Analyst ratings

97%

of 37 ratings
Buy
97.3%
Hold
2.7%
Sell
0%

More BSX News

Simply Wall St 3d
Boston Scientific Faces EP Lawsuits As Trials And New Devices Shift Outlook

Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX) alleging misrepresentation of growth prospects in its U.S. Electr...

Boston Scientific Faces EP Lawsuits As Trials And New Devices Shift Outlook
Simply Wall St 4d
Do Boston Scientific’s WATCHMAN Win and Asurys Launch Quietly Recast Its Long-Term Growth Story?

In late March 2026, Boston Scientific announced landmark CHAMPION-AF trial results showing its WATCHMAN FLX left atrial appendage closure device matched non-vit...

Do Boston Scientific’s WATCHMAN Win and Asurys Launch Quietly Recast Its Long-Term Growth Story?
TipRanks 6d
Boston Scientific Investors File Lawsuit Over Alleged Misleading Statements About Electrophysiology Business Growth

Boston Scientific (BSX) projected strong growth. They said their heart-device technology was gaining share in the market. Investors were told the momentum would...

Simply Wall St 6d
Is There An Opportunity In Boston Scientific After Steep Recent Share Price Declines?

If you are wondering whether Boston Scientific at around US$62.93 still offers value, the key question is how its current price lines up with the cash flows and...

Is There An Opportunity In Boston Scientific After Steep Recent Share Price Declines?
Nasdaq 7d
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results

Boston Scientific (NYSE:BSX), a maker of medical devices for interventional specialties, closed Monday at $62.92, down 9.03%. The stock moved lower on Monday as...

Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
Barron's 7d
Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data.

Feature Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. In this article BSX SPX Boston Scientific stock was on pace for i...

Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data.
TipRanks 7d
FTC issued Second Request to Penumbra, Boston Scientific over merger review

According to a regulatory filing, Penumbra (PEN) and Boston Scientific (BSX) each filed a notification and report form under the HSR Act with the DOJ and the FT...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.